Which ulcer‑prophylaxis medication for patients on chronic non‑steroidal anti‑inflammatory drugs is contraindicated in pregnancy: pantoprazole (Protonix), famotidine (Pepcid), misoprostol (Cytotec), or sucralfate (Carafate)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Misoprostol (Cytotec) is Absolutely Contraindicated During Pregnancy

Misoprostol (Cytotec) is the medication that is contraindicated during pregnancy among the options listed. This prostaglandin E1 analog carries an FDA black box warning specifically prohibiting its use for NSAID-induced ulcer prophylaxis in pregnant women due to its potent abortifacient properties. 1

Why Misoprostol is Contraindicated

FDA Black Box Warning and Mechanism

  • Misoprostol administration to pregnant women can cause abortion, premature birth, birth defects, and uterine rupture. The FDA explicitly states that misoprostol should NOT be taken by pregnant women to reduce the risk of NSAID-induced ulcers. 1

  • The drug's mechanism as a prostaglandin E1 analog causes cervical ripening and powerful uterotonic effects, making it highly effective at terminating pregnancies across all trimesters. 2, 3

  • Uterine rupture has been specifically reported when misoprostol was administered in pregnant women, particularly when used to induce labor or abortion beyond the eighth week of pregnancy. 1

Teratogenic Effects When Pregnancy Continues

  • Beyond its abortifacient properties, misoprostol is associated with specific teratogenic effects if the pregnancy continues after exposure, including limb defects and Möbius syndrome. 3

  • Healthcare providers must recognize these associated teratogenic effects and provide thorough consultation before prescribing this medication, especially regarding risks if abortion fails. 3

Strict Prescribing Requirements (If Ever Used in Women of Childbearing Age)

The FDA mandates that if misoprostol must be prescribed to a woman of childbearing potential for ulcer prophylaxis, ALL of the following conditions must be met: 1

  • Patient must be at high risk of complications from gastric ulcers associated with NSAID use OR at high risk of developing gastric ulceration
  • Negative serum pregnancy test within 2 weeks prior to beginning therapy
  • Patient is capable of complying with effective contraceptive measures
  • Patient has received both oral AND written warnings about the hazards
  • Therapy begins only on the second or third day of the next normal menstrual period

Why the Other Options Are NOT Contraindicated

Pantoprazole (Protonix) - Safe in Pregnancy

  • Proton pump inhibitors, including pantoprazole, are not associated with increased risk of congenital malformations, premature births, stillbirths, spontaneous abortions, or low birth weight. 4

  • PPIs can be used throughout pregnancy when clinically indicated for GERD or ulcer prophylaxis.

Famotidine (Pepcid) - Safe in Pregnancy

  • H2-receptor antagonists like famotidine have an established safety profile in pregnancy with no evidence of teratogenicity.

  • These medications are commonly used for acid suppression throughout all trimesters without contraindication.

Sucralfate (Carafate) - Safe in Pregnancy

  • Sucralfate acts locally in the gastrointestinal tract with minimal systemic absorption, making it one of the safest options for ulcer treatment during pregnancy.

  • It can be used throughout pregnancy without restriction.

Clinical Bottom Line

For pregnant patients requiring NSAID-induced ulcer prophylaxis, use pantoprazole, famotidine, or sucralfate—NEVER misoprostol. 1 The abortifacient and teratogenic properties of misoprostol make it absolutely contraindicated for this indication during pregnancy, as explicitly stated in FDA labeling and multiple clinical guidelines. 1, 2, 3

If a woman of childbearing age requires chronic NSAID therapy with ulcer prophylaxis, counsel her about pregnancy risks and ensure effective contraception if misoprostol is being considered, or preferentially choose alternative gastroprotective agents that are pregnancy-compatible. 1

References

Research

Misoprostol: a quarter century of use, abuse, and creative misuse.

Obstetrical & gynecological survey, 2004

Research

The use of misoprostol in termination of second-trimester pregnancy.

Taiwanese journal of obstetrics & gynecology, 2011

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.